Abstract

Diabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cerebral vessel damage. DM complications can reduce quality of life and shorten life spans and eventually also impede social and economic development. Therefore, effective measures to curb the occurrence and development of diabetes assist in improving patients' quality of life, delay the progression of DM in the population, and ease a social burden. The liver is regarded as an important link in the management and control of DM, including the alleviation of glucose metabolism and lipid metabolism and others via glucose storage and endogenous glucose generation from glycogen stored in the liver. Liver cirrhosis is a very common chronic disease, which often lowers the quality of life and decreases life expectancy. According to a growing body of research, diabetes shows a close correlation with hepatitis, liver cirrhosis, and liver cancer. Moreover, coexistence of liver complications would accelerate the deterioration of patients with diabetes. Liver cirrhosis and diabetes influence each other. Thus, in addition to pharmacological treatments and lifestyle interventions, effective control of cirrhosis might assist in a better management of diabetes. When it comes to different etiologies of liver cirrhosis, different therapeutic methods, such as antiviral treatment, may be more effective. Effective control of cirrhosis might be a strategy for better management of diabetes.

Highlights

  • In 2015, there were approximately 415 million diabetes mellitus (DM) patients aged 20 to 79 years old, and researchers estimated approximately 642 million new patients within the 2 decades [1]

  • There are several different nonalcoholic fatty liver disease (NAFLD) patterns based on their pathological features, including steatosis, nonalcoholic steatohepatitis (NASH), and cirrhosis accompanied by even hepatocellular carcinoma (HCC)

  • A meta-analysis containing 19 studies suggested that NAFLD increased the risk of DM (random-effects hazard ratio (HR) 2.22) in contrast to those with non-NAFLD, and the 95% confidence interval (CI) for it was 1.84-2.60; patients with cirrhosis were more prone to the progression of DM [15]

Read more

Summary

Introduction

In 2015, there were approximately 415 million diabetes mellitus (DM) patients aged 20 to 79 years old, and researchers estimated approximately 642 million new patients within the 2 decades [1]. Cirrhosis is the 11th most common cause of mortality, leading to 1.16 million civilian deaths per year around the world [7]. Journal of Diabetes Research of nonalcoholic fatty liver disease (NAFLD), viruses, and excessive alcohol consumption. Epidemiological Characteristics of NAFLD or Alcoholic Liver Disease (ALD). There are several different NAFLD patterns based on their pathological features, including steatosis, nonalcoholic steatohepatitis (NASH), and cirrhosis accompanied by even hepatocellular carcinoma (HCC). According to the pathological characteristics, ALD can be divided into three stages: simple steatosis, steatohepatitis, and hepatic fibrosis or cirrhosis. NAFLD influences the burden of liverrelated morbidity and mortality, such as severely impairing hepatic structure and function, with cirrhotic liver failure and HCC, and extrahepatic complications like DM [11]

Interaction between DM and NAFLD or ALD
Interaction between DM and HCV-Induced Diseases
Interaction between DM and HBV-Related Diseases
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call